338 related articles for article (PubMed ID: 34671197)
1. Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor.
Zhou Y; Liu S; Liu C; Yang J; Lin Q; Zheng S; Chen C; Zhou Q; Chen R
Int J Biol Sci; 2021; 17(14):3760-3775. PubMed ID: 34671197
[No Abstract] [Full Text] [Related]
2. Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing.
Chen P; Wang Y; Li J; Bo X; Wang J; Nan L; Wang C; Ba Q; Liu H; Wang H
Clin Transl Med; 2021 Jun; 11(6):e462. PubMed ID: 34185421
[TBL] [Abstract][Full Text] [Related]
3. Comparative single-cell RNA sequencing (scRNA-seq) reveals liver metastasis-specific targets in a patient with small intestinal neuroendocrine cancer.
Rao M; Oh K; Moffitt R; Thompson P; Li J; Liu J; Sasson A; Georgakis G; Kim J; Choi M; Powers S
Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32054662
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing.
Wong HL; Yang KC; Shen Y; Zhao EY; Loree JM; Kennecke HF; Kalloger SE; Karasinska JM; Lim HJ; Mungall AJ; Feng X; Davies JM; Schrader K; Zhou C; Karsan A; Jones SJM; Laskin J; Marra MA; Schaeffer DF; Gorski SM; Renouf DJ
Cold Spring Harb Mol Case Stud; 2018 Feb; 4(1):. PubMed ID: 29092957
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.
Scott AT; Weitz M; Breheny PJ; Ear PH; Darbro B; Brown BJ; Braun TA; Li G; Umesalma S; Kaemmer CA; Maharjan CK; Quelle DE; Bellizzi AM; Chandrasekharan C; Dillon JS; O'Dorisio TM; Howe JR
Clin Cancer Res; 2020 Apr; 26(8):2011-2021. PubMed ID: 31937620
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.
Peng J; Sun BF; Chen CY; Zhou JY; Chen YS; Chen H; Liu L; Huang D; Jiang J; Cui GS; Yang Y; Wang W; Guo D; Dai M; Guo J; Zhang T; Liao Q; Liu Y; Zhao YL; Han DL; Zhao Y; Yang YG; Wu W
Cell Res; 2019 Sep; 29(9):725-738. PubMed ID: 31273297
[TBL] [Abstract][Full Text] [Related]
7. EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors.
Saller J; Seydafkan S; Shahid M; Gadara M; Cives M; Eschrich SA; Boulware D; Strosberg JR; Aejaz N; Coppola D
Cancer Genomics Proteomics; 2019; 16(5):309-318. PubMed ID: 31467225
[TBL] [Abstract][Full Text] [Related]
8. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
[TBL] [Abstract][Full Text] [Related]
9. CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors.
Miki M; Oono T; Fujimori N; Takaoka T; Kawabe K; Miyasaka Y; Ohtsuka T; Saito D; Nakamura M; Ohkawa Y; Oda Y; Suyama M; Ito T; Ogawa Y
Cancer Med; 2019 Jul; 8(8):3748-3760. PubMed ID: 31129920
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
Front Immunol; 2021; 12():648917. PubMed ID: 33777046
[No Abstract] [Full Text] [Related]
11. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
[TBL] [Abstract][Full Text] [Related]
12. Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing Data.
Davis-Marcisak EF; Sherman TD; Orugunta P; Stein-O'Brien GL; Puram SV; Roussos Torres ET; Hopkins AC; Jaffee EM; Favorov AV; Afsari B; Goff LA; Fertig EJ
Cancer Res; 2019 Oct; 79(19):5102-5112. PubMed ID: 31337651
[TBL] [Abstract][Full Text] [Related]
13. Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors.
Yan N; Xie W; Wang D; Fang Q; Guo J; Chen Y; Li X; Gong L; Wang J; Guo W; Zhang X; Zhang Y; Gu J; Li C
Genome Med; 2024 Jan; 16(1):2. PubMed ID: 38167466
[TBL] [Abstract][Full Text] [Related]
14. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
[TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA sequencing in cancer research.
Zhang Y; Wang D; Peng M; Tang L; Ouyang J; Xiong F; Guo C; Tang Y; Zhou Y; Liao Q; Wu X; Wang H; Yu J; Li Y; Li X; Li G; Zeng Z; Tan Y; Xiong W
J Exp Clin Cancer Res; 2021 Mar; 40(1):81. PubMed ID: 33648534
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.
Carr JC; Sherman SK; Wang D; Dahdaleh FS; Bellizzi AM; O'Dorisio MS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S739-S746. PubMed ID: 24114056
[TBL] [Abstract][Full Text] [Related]
17. UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
Finnerty BM; Moore MD; Verma A; Aronova A; Huang S; Edwards DP; Chen Z; Seandel M; Scognamiglio T; Du YN; Elemento O; Zarnegar R; Min IM; Fahey TJ
Endocr Relat Cancer; 2019 Apr; 26(4):411-423. PubMed ID: 30689542
[TBL] [Abstract][Full Text] [Related]
18. Cell Heterogeneity Analysis in Single-Cell RNA-seq Data Using Mixture Exponential Graph and Markov Random Field Model.
Wang Y; Tian X; Ai D
Biomed Res Int; 2021; 2021():9919080. PubMed ID: 34095314
[TBL] [Abstract][Full Text] [Related]
19. Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing.
Cao YH; Ding J; Tang QH; Zhang J; Huang ZY; Tang XM; Liu JB; Ma YS; Fu D
Bioengineered; 2022; 13(7-12):14974-14986. PubMed ID: 37105769
[TBL] [Abstract][Full Text] [Related]
20. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]